OpenAI acquires Orchestra Bio to strengthen life-sciences AI and Rosalind
OpenAI has acquired the startup Orchestra Bio, adding its team and technology to its biotech efforts. The acquired capabilities will support Rosalind, OpenAI's AI model for life-sciences research, and Rosalind Workbench, a tool for planning experiments and analyzing results. The deal signals continued investment in applying AI to scientific research workflows.